Psychiatry Flashcards
what medication can be used to treat sleep paralysis?
clonazepam
overdose antidotes
paracetamol --> N-acetylcysteine opiates --> naloxone benzodiazepines --> flumazenil warfarin --> vitamin K beta-blockers --> glucagon TCAs --> sodium bicarbonate organophosphates --> atropine
pregabalin
used in GAD and neuropathic pain
is an anticonvulsant
ADR: dizziness, drowsiness, blurred vision, diplopia, confusion and vivid dreams
beta-blockers
e.g. propranolol
reduces somatic symptoms of GAD
CI in asthma
lamotrigine
anticonvulsant
used to treat BPAD as a mood stabilisers
less teratogenic than other mood stabilisers so used in women of child bearing age
ADR:
GI disturbance, rash, headache, tremor, patient must be informed to see doctor if signs of hypersensitivity reaction
avoid abrupt withdrawal
carbamazepine
used in epilepsy, neuropathic pain, alcohol withdrawal and BPAD unresponsive to lithium
blocks voltage dependent Na+ channels so prevents repetitive neuronal firing
ADR:
GI upset, dermatitis, dizziness, hyponatraemia, leukopenia and thrombocytopenia (monitor WCC after 1 week)
CI in pregnancy, AV conduction abnormalities and acute porphyria
sodium valproate
used to treat epilepsy (IV), BPAD (with lithium for rapidly cycling) and to prevent migraines
avoid in hepatic dysfunction, porphyria and pregnancy
ADR: “GI VALPROATE”
GI upset, very fat (weight gain), aggression, LFTs (increased), platelets (low - thrombocytopenia), reversible hair loss, oedema (peripheral), ataxia, tiredness/tremor/teratogenic, emesis
Lithium
1st line prophylaxis in BPAD, possible adjunct for depression
ADR: “GI LITHIUM”
GI upset, leucocytosis, impaired renal function, tremor (fine)/teratogenic/thirst (polydipsia), hypothyroidism/hair loss, increased weight and fluid retention, urine (polyuria), metallic taste
in TOXICITY
enhanced by DEHYDRATION, DRUGS (NSAIDS, ACEi), diuretics (thiazide), depletion of NA+
symptoms in toxicity “TOXIC” -
tremor (coarse), oliguric renal failure, ataxia, increased reflexes, convulsions/ coma/ consciousness reduced
normal therapeutic levels are 0.4-1.0mmol/l, toxic at 1.5 mmol/l - very narrow therapeutic window (must monitor levels 12hrs after first dose, then weekly until within range and stable for four weeks and then every three months)
antipsychotics
typical (e.g. haloperidol) more extra-pyramidal side effects, generally less tolerable, cause high prolactin
atypical (e.g. olanzapine, clozapine) are more likely to cause weight gain, T2DM, metabolic syndrome and stroke in the elderly.
haloperidol
typical antipsychotic
most ADRs, prolonged QTc (needs ECG monitoring)
available as a depot every 4 weeks
risk of neuroleptic malignant syndrome, extra-pyramidal side effects
sulpiride
typical antipsychotic
least ADRs, doesn’t really affect blood pressure
not available IM
chlorpromazine
typical antipsychotic
mainly used PO
risk of neuroleptic malignant syndrome
olanzapine
atypical antipsychotic causes the most weight gain need a fasting glucose baseline, at 1 month and then every 4-6 months an antidepressant at a low dose available as a depot
clozapine
atypical antipsychotic
used in treatment resistant schizophrenia
need a fasting glucose baseline, at 1 month and then every 4-6 months
reduces seizure threshold, causes hypersalivation
good for negative symptoms
not available IM
causes neutropenia and agranulocytosis (need weekly WCC for 18 weeks, fortnightly for 1 year and then every 4-6 months)
risperidone
atypical antipsychotic
anti-manic at high dose (but increased risk of EPSE)
causes hyperprolactinaemia so avoid in women
aripiprazole
atypical antipsychotic
less ADRs, useful in the 1st episode of psychosis, doesn’t affect BP, available as a depot
quetiapine
atypical antipsychotic
used in BPAD during a depressive episode
not available IM
antipsychotics side effects
anti-dopaminergic (EPSE - more common in typical)
serotonergic (improves affective and negative symptoms, responsible for metabolic symptoms - mainly atypical)
anti-histaminergic (causes weight gain and sedation)
anti-adrenergic (postural hypotension, tachycardia, and ejaculation failure)
anti-cholinergic and anti-muscarinic (can’t pee, can’t see, can’t sit, can’t shit)
extrapyramidal side effects
- parkinsonism; bradykinesia, increased rigidity, coarse tremor, masked facies, shuffling gait, takes weeks-months to develop
- akathisia: unpleasant feeling of restlessness, occurs in the first months of treatment, reduce dose and give propranolol temporarily
- dystonia: acute painful spasms of the neck muscles, jaw and eyes (oculogyric crisis), can occur within days
- tardive dyskinesia: late onset (years) in 40% of patients, may be irreversible - choreoathetoid movements: abnormal, involuntary movements, most commonly presents as chewing or pouting
neuroleptic malignant syndrome
a rare, life-threatening condition seen in patients taking antipsychotics in first 10 days or after increasing the dose
10% mortality
pyrexia, muscle rigidity, confusion, fluctuating consciousness and autonomic instability +/- delirium
Ix: increased creatinine kinase, leucocytosis, deranged LFTs
Rx: stop drug, monitor, IVF, cooling, dantrolene (muscle relaxant), bromocriptine (dopamine agonist), benzodiazepine
complications: PE, renal failure, shock